Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Infective endocarditis following transcatheter aortic valve replacement-: Diagnostic and management challenges

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Clinical evaluation of the Hydra self-expanding transcatheter aortic valve: 6 month results from the GENESIS trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Impact of early hospital discharge on clinical outcomes after transcatheter aortic valve implantation

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Coagulation parameters in the newborn and infant - the Copenhagen Baby Heart and COMPARE studies

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Lipoprotein(a) levels at birth and in early childhood: The COMPARE Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Ticagrelor and the risk of Staphylococcus aureus bacteraemia and other infections

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Lung Ultrasound Findings Associated With COVID-19 ARDS, ICU Admission, and All-Cause Mortality

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Long-Term Changes in Invasive Physiological Pressure Indices of Stenosis Severity Following Transcatheter Aortic Valve Implantation

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
Transcatheter aortic valve replacement (TAVR) can improve the symptoms and prognosis of patients with severe aortic stenosis who, due to a high expected operative risk, would not have otherwise been treated surgically. If these patients develop prosthetic valve endocarditis, their presentations may be atypical causing a delay in the diagnosis and treatment. The management is also complicated by their comorbidities, and surgical treatment may not be feasible leading to a significant morbidity and mortality. We describe a case of an 85-year-old man with TAVI prosthetic valve endocarditis successfully treated medically, discuss the challenges in the diagnosis and management of such patients, and review available literature on the incidence and outcome of the condition. © 2012 Wiley Periodicals, Inc.
Original languageEnglish
JournalCatheterization and Cardiovascular Interventions
Volume81
Issue number4
Pages (from-to)623-27
ISSN1522-1946
DOIs
Publication statusPublished - 2013

ID: 36807483